IgIV para la enfermedad hemolítica isoinmune del recién nacido (EHRN)

Healthcare providers sometimes recommend IVIG treatment when first-line treatment, like phototherapy, is insufficient for newborns with isoimmune hemolytic disease (HDN). Isoimmune hemolytic disease of the newborn is a potentially life-threatening condition that develops when there is a blood group incompatibility between...

Leer más